3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
16
Triple Negative Breast Neoplasms
5
Stomach Neoplasms
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Esophageal Neoplasms
4
Adenocarcinoma Of Esophagus
4
Neoplasms
3
Neoplasm Metastasis
3
Nasopharyngeal Carcinoma
3
Adenocarcinoma
3
Colorectal Neoplasms
2
Biliary Tract Neoplasms
2
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Locally Advanced Gastric Cancer
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Clinical Stage I Gastric Cancer AJCC v8
1
Childhood Solid Tumor
1
Breast Neoplasm Malignant Female
1
Brain Neoplasms
1
Advanced Solid Tumour
1
Advanced Rectal Cancer
1
Adjuvant Drug Therapy
1
Interventions
durvalumab
3
abemaciclib
2
Pemetrexed
2
Fulvestrant
2
Cisplatin
2
Carboplatin
2
ribociclib
1
repotrectinib
1
pembrolizumab
1
palbociclib
1
exemestane
1
elacestrant
1
cemiplimab
1
atezolizumab
1
Tamoxifen
1
STX-478
1
RAD1901
1
Nivolumab
1
Metformin
1
Letrozole
1
Immunotherapy
1
Imlunestrant
1
Drug Therapy
1
Docetaxel
1
Bevacizumab
1
Anastrozole
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms by Site
×
Capecitabine
×
30 days
×
Clear all
No trials found.